Get the Stockscreener App
2.33
2.10%
-0.05
Phio Pharmaceuticals Corp stock is traded at $2.33, with a volume of 218.66K.
It is down -2.10% in the last 24 hours and down -6.05% over the past month.
Phio Pharmaceuticals Corp is a clinical-stage biotechnology company whose proprietary INTASYL self-delivering RNAi technology platform is designed to make immune cells more effective in killing tumor cells. The Company is developing therapeutics that are designed to leverage INTASYL to precisely target specific proteins that reduce the body's ability to fight cancer, without the need for specialized formulations or drug delivery systems.
See More
Previous Close:
$2.38
Open:
$2.41
24h Volume:
218.66K
Relative Volume:
0.17
Market Cap:
$11.18M
Revenue:
-
Net Income/Loss:
$-11.66M
P/E Ratio:
-0.2857
EPS:
-8.156
Net Cash Flow:
$-11.09M
1W Performance:
-14.96%
1M Performance:
-6.05%
6M Performance:
+13.11%
1Y Performance:
-21.42%
1-Day Range:
$2.27
$2.41
1-Week Range:
$2.27
$2.70
52-Week Range:
$0.9657
$9.79
Phio Pharmaceuticals Corp Stock (PHIO) Company Profile
Name
Phio Pharmaceuticals Corp
Sector
Industry
Phone
(508) 767-3861
Address
11 APEX DRIVE, SUITE 300A, MARLBOROUGH, MA
Compare PHIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PHIO
Phio Pharmaceuticals Corp
|
2.33 | 11.42M | 0 | -11.66M | -11.09M | -8.156 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Phio Pharmaceuticals Corp Stock (PHIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jun-05-25 | Resumed | H.C. Wainwright | Buy |
| Aug-05-20 | Initiated | H.C. Wainwright | Buy |
Phio Pharmaceuticals Corp Stock (PHIO) Latest News
What is the risk reward ratio of investing in Phio Pharmaceuticals Corp. stockPost Market Opportunities With High Returns - jammulinksnews.com
What analysts say about Phio Pharmaceuticals Corp. stock outlookEntry Level Investment Outlook Forecast - beatles.ru
Is it the right time to buy Phio Pharmaceuticals Corp. stockMarket Forecast Planner To Watch Now - jammulinksnews.com
Real time alert setup for Phio Pharmaceuticals Corp. performanceTrade Setups With Clear Risk Limits Highlighted - metal.it
What makes Phio Pharmaceuticals Corp. stock price move sharplyWealth Building Planner With Proven Results - jammulinksnews.com
Phio Pharmaceuticals Issues New Warrants for $2.5M - TipRanks
Trading Bots Trigger Alerts on Phio Pharmaceuticals Corp. ActivityTrend Analysis for Safer Trades Gains Popularity - metal.it
What are the latest earnings results for Phio Pharmaceuticals Corp.Free Bull & Bear Market Updates - jammulinksnews.com
Evaluating Phio Pharmaceuticals Corp. with trendline analysisHigh Return Idea With Technical Filter - Newser
Is Phio Pharmaceuticals Corp. Stock a Smart Buy in 2025 Investment Analysis InsideFree Growth Investment Group - Newser
Is Phio Pharmaceuticals Corp. stock overvalued or undervaluedUnlock real-time stock alerts for quick profits - jammulinksnews.com
How does Phio Pharmaceuticals Corp. generate profit in a changing economyFree Capital Allocation Plans - jammulinksnews.com
What are Phio Pharmaceuticals Corp. company’s key revenue driversMarket Forecast Review For 2025 - jammulinksnews.com
Does Phio Pharmaceuticals Corp. stock perform well during market downturnsBreakneck growth rates - jammulinksnews.com
How volatile is Phio Pharmaceuticals Corp. stock compared to the marketOverwhelming profit margins - jammulinksnews.com
What institutional investors are buying Phio Pharmaceuticals Corp. stockGet real-time alerts on top-performing stocks - jammulinksnews.com
Why Phio Pharmaceuticals Corp. stock attracts strong analyst attentionMarket Timing Advice - Newser
Is Phio Pharmaceuticals Corp. Stock Overbought or Oversold RSI Indicator AnalysisShort Term High Return Strategy - Newser
Phio Pharmaceuticals Announces New Manufacturing Agreement - MSN
PHIO Stock’s Unexpected Rise: What’s Next? - timothysykes.com
Phio Pharmaceuticals Announces Exercise of Warrants for Approximately $2.5 Million Gross Proceeds - TradingView
Phio Pharmaceuticals Corp. Stock Analysis and ForecastConsistent wealth multiplication - PrintWeekIndia
Clinical Trial Success: Phio's Cancer Drug Shows 100% Tumor Clearance in Latest Results - Stock Titan
PHIO’s Unexpected Climb: What’s Driving the Surge? - StocksToTrade
Phio Pharmaceuticals stock soars after manufacturing agreement By Investing.com - Investing.com Canada
Phio Pharmaceuticals stock soars after manufacturing agreement - Investing.com
Phio Pharmaceuticals signs manufacturing agreement for cancer drug - Investing.com
Phio Pharmaceuticals signs manufacturing agreement for cancer drug By Investing.com - Investing.com South Africa
Phio Pharmaceuticals Announces Agreement with U.S. Manufacturing Source for Drug Substance - Newsfile
Is Phio Pharmaceuticals Corp. a good long term investmentBreakout stock performance - jammulinksnews.com
What analysts say about Phio Pharmaceuticals Corp. stockPhenomenal trading returns - jammulinksnews.com
What drives Phio Pharmaceuticals Corp. stock priceSuperior returns - jammulinksnews.com
Phio Pharmaceuticals Corp Stock (PHIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):